Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

Antibody response to breakthrough SARS-CoV-2 infection in “booster” vaccinated patients with multiple myeloma according to B/T/NK lymphocyte absolute counts and anti-CD38 treatments

Bibliographic Details
Main Authors:	NICOLA SGHERZA, Anna Mestice, Angela Maria Vittoria Larocca, Pellegrino Musto
Format:	Article
Language:	English
Published:	PAGEPress Publications 2024-02-01
Series:	Mediterranean Journal of Hematology and Infectious Diseases
Subjects:	breakthrough SARS-CoV-2 infection, multiple myeloma, serological response
Online Access:	https://www.mjhid.org/mjhid/article/view/5618

Similar Items

EFFECTS OF DARATUMUMAB ON HEMATOPOIETIC STEM CELLS IN PATIENTS WITH MULTIPLE MYELOMA WHO ARE PLANNED TO RECEIVE AUTOLOGOUS TRANSPLANTATION: WHAT’S THE RELEVANCE?
by: Pellegrino Musto, et al.
Published: (2024-08-01)

Humoral immune response after anti-SARS-CoV-2 vaccine “booster” dose in patients with monoclonal gammopathy of undetermined significance (MGUS)
by: NICOLA SGHERZA, et al.
Published: (2023-01-01)

Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination
by: Sharon Walmsley, et al.
Published: (2023-12-01)

Predictive role of absolute lymphocyte count in daratumumab-treated patients with relapsed/refractory multiple myeloma
by: Hee Jeong Cho, et al.
Published: (2023-03-01)

Is the serum light chain quantification more sensitive than immunofixation in the diagnosis and follow up of patients with multiple myeloma ?
by: Guillermo José Ruiz-Argüelles
Published: (2014-08-01)

Breakthrough Infections in SARS-CoV-2-Vaccinated Multiple Myeloma Patients Improve Cross-Protection against Omicron Variants
by: Angelika Wagner, et al.
Published: (2024-05-01)

Breakthrough infections and acceptance of COVID-19 vaccine boosters: A survey analysis
by: Christina W. Stevens, et al.
Published: (2023-12-01)

BREAKTHROUGH ECONOMY: FEATURES OF FORMATION AND DEVELOPMENT IN RUSSIA
by: E. Bykovskaia, et al.
Published: (2019-11-01)

A breakthrough economy: On the theory of economic systems change management
by: Matskulyak I.D., et al.
Published: (2019-09-01)

Clinical and microbiological analysis of risk factors for breakthrough bloodstream infection during Tigecycline Therapy
by: Sol Jin, et al.
Published: (2025-02-01)

Are Open Innovation and Entrepreneurial Intentions complements or substitutes for the successful commercialization of academic Breakthrough Technologies?
by: Marielle Feenstra, et al.
Published: (2024-05-01)

A Breakthrough Economy Management
by: I. D. Matskuluyak, et al.
Published: (2021-04-01)

Using Multimodal Analgesia for Breakthrough Pain in Stage IV Breast Cancer Patient
by: Indriyani Wijaya, et al.
Published: (2023-01-01)

Role and Modulation of NK Cells in Multiple Myeloma
by: Marie Thérèse Rubio, et al.
Published: (2021-04-01)

Contours of the technological breakthrough in Russia and the Orenburg region
by: M.G. Lapaeva, et al.
Published: (2019-04-01)

Breakthrough pressure and permeability of hydrophobic sands
by: Sheikh Sulaiman Bin Mohammad Bahajjaj
Published: (2024)

Mucosal antibody responses to SARS-CoV-2 booster vaccination and breakthrough infection
by: Disha Bhavsar, et al.
Published: (2023-12-01)

Serological follow-up of anti-SARS-CoV-2 antibodies in blood donors after COVID-19 vaccine booster dose and breakthrough infections in Fuzhou
by: Shuhua JI, et al.
Published: (2023-12-01)

The Dependence of Water and Gas Breakthrough on the Choice of Model Parameters in Naturally Fractured Reservoirs Using Sector and Full Reservoir Models
by: Barham Sabir Mahmood, et al.
Published: (2024-05-01)

Individuals With Weaker Antibody Responses After Booster Immunization Are Prone to Omicron Breakthrough Infections
by: Birte Möhlendick, et al.
Published: (2022-06-01)

NK cells and CD38: Implication for (Immuno)Therapy in Plasma Cell Dyscrasias
by: Renato Zambello, et al.
Published: (2020-03-01)

Single VHH-directed BCMA CAR-NK cells for multiple myeloma
by: Quan Ren, et al.
Published: (2023-11-01)

Breakthrough pain among cancer patients at oncology units in Northern Ethiopia; a multi-center study
by: Yohanes Tekie, et al.
Published: (2024-01-01)

Epidemiological characteristics of breakthrough mumps infection cases from 2019 to 2023 in Chongqing, China
by: Yang Liu, et al.
Published: (2024-12-01)

Predicting Scientific Breakthroughs Based on Structural Dynamic of Citation Cascades
by: Houqiang Yu, et al.
Published: (2024-06-01)

Career Breakthroughs of Women in Intercollegiate Athletic Administration
by: Meg G. Hancock, et al.
Published: (2017-12-01)

Single-cell transcriptome atlas of peripheral immune features to Omicron breakthrough infection under booster vaccination strategies
by: Yuwei Zhang, et al.
Published: (2025-01-01)

Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myeloma
by: Jingjing Pu, et al.
Published: (2024-10-01)

Normalisation of haemoglobin and control of breakthrough haemolysis with increased frequency pegcetacoplan dosing in treated paroxysmal nocturnal haemoglobinuria
by: Amanda K. Davis, et al.
Published: (2023-08-01)

Oncolytic viruses: a potential breakthrough immunotherapy for multiple myeloma patients
by: Vincenzo Raimondi, et al.
Published: (2024-10-01)

Symptomatic SARS-CoV-2 breakthrough with delta variant after 3rd mRNA vaccine shot (booster)
by: Verena Schildgen, et al.
Published: (2022-04-01)

Serum free light chains and multiple myeloma: Is it time to extend their application?
by: Uros Markovic, et al.
Published: (2020-04-01)

Drug Conjugated and Bispecific Antibodies for Multiple Myeloma: Improving Immunotherapies off the Shelf
by: Gregorio Barilà, et al.
Published: (2021-01-01)

Controversy in the Use of CD38 Antibody for Treatment of Myeloma: Is High CD38 Expression Good or Bad?
by: Torben Plesner, et al.
Published: (2020-02-01)

Characteristics of humoral responses to the first coronavirus disease booster vaccine and breakthrough infection in central China: a multicentre, prospective, longitudinal cohort study
by: Junhong Xu, et al.
Published: (2025-01-01)

COVID–19 breakthrough infection after four doses of the vaccines: A case report
by: Hongrang Zhou, et al.
Published: (2023-01-01)

Effects of antivirals on patients with COVID-19 breakthrough
by: Hong Tham Pham, et al.
Published: (2024-01-01)

Harnessing the Potential of NK Cell-Based Immunotherapies against Multiple Myeloma
by: Chantal Reina-Ortiz, et al.
Published: (2022-01-01)

The real‐world use and efficacy of pomalidomide for relapsed and refractory multiple myeloma in the era of CD38 antibodies
by: Agoston Gyula Szabo, et al.
Published: (2023-11-01)

Donor Lymphocyte Infusion to Enhance the Graft-versus-Myeloma Effect
by: Nico Gagelmann, et al.
Published: (2021-04-01)